BREAKTHROUGH: Israel Close To Coronavirus Vaccine


( – Once again, Israel is at the forefront of biotech breakthroughs and is reportedly close to developing a vaccine for the coronavirus. Scientists claim that they are just weeks away from developing the first-ever vaccine for the virus that is quickly spreading across the world. Once ready and tested, the vaccine could be available for distribution within another 90 days.

The Jerusalem Post reports that Israel’s Science and Technology Minister, OfirAkunis, congratulated The Galilee Research Institute (MIGAL) on their “exciting breakthrough”

“I am confident there will be further rapid progress, enabling us to provide a needed response to the grave COVID-19 threats,” he said.

The team producing the virus were previously working on a vaccine against the bronchitis virus (IBV), but have turned their focus to tackling the immediate threat of the coronavirus. Dr. Chen Katz, biotechnology group leader at MIGAL, said their “basic concept was to develop the technology and not specifically a vaccine for this kind or that kind of virus.”

“The scientific framework for the vaccine is based on a new protein expression vector, which forms and secretes a chimeric soluble protein that delivers the viral antigen into mucosal tissues by self-activated endocytosis, causing the body to form antibodies against the virus.”

Put simply, the vaccine technology developed by these Israeli scientists is designed to assist the body in the natural production of antibodies against a variety of viruses, and not just equip it to deal with one certain strain.

“Let’s call it pure luck,” Katz added. “We decided to choose coronavirus as a model for our system just as a proof of concept for our technology.”

The term “coronavirus” refers to a kind of virus which can have many different strains, meaning the virus existed before the most recent outbreak but exists in many different forms.

According to the Jerusalem Post, the likelihood of developing a vaccine for human use in a short period of time is high as a result of scientists’ findings. MIGAL researchers found that the poultry coronavirus, which affects birds, is close enough to the human version. Because they both use the same infection mechanism, it is easier to produce a vaccine for humans.

Katz explained, “All we need to do is adjust the system to the new sequence. We are in the middle of this process, and hopefully, in a few weeks, we will have the vaccine in our hands. Yes, in a few weeks, if it all works, we would have a vaccine to prevent coronavirus.” Thanks, Israel!